Abstract | BACKGROUND: Safety warnings from health authorities are currently intended to limit the use of psychotropic agents in dementia-related conditions. Evidence concerning the use of antidepressants in dementia is, however, scarce and contradictory. OBJECTIVE: METHOD: RESULTS: Multivariate analysis showed an annual significant increase (pā<ā0.001) in the prescription rate of antidepressants from 26% (2010) to 31% (2014), and identified female gender, younger age, higher education, living in long-term facilities, more severe cognitive decline, and presence of vascular signs (VaD and MD) as associated factors for antidepressant prescribing. CONCLUSION: The annual increase of antidepressant prescribing among individuals with AD, MD, and VaD in French specialized settings may be partially related to the lack of current valuable medications for dementia-related behavioral symptoms.
|
Authors | Renaud David, Valeria Manera, Roxane Fabre, Christian Pradier, Philippe Robert, Karim Tifratene |
Journal | Journal of Alzheimer's disease : JAD
(J Alzheimers Dis)
Vol. 53
Issue 4
Pg. 1365-73
(07 02 2016)
ISSN: 1875-8908 [Electronic] Netherlands |
PMID | 27392860
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Age Factors
- Aged
- Aged, 80 and over
- Antidepressive Agents
(therapeutic use)
- Cerebrovascular Disorders
(drug therapy, epidemiology)
- Cross-Sectional Studies
- Dementia
(drug therapy, epidemiology)
- Educational Status
- Female
- France
- Humans
- Male
- Multivariate Analysis
- Practice Patterns, Physicians'
(trends)
- Prevalence
- Residential Facilities
- Severity of Illness Index
- Sex Factors
|